Naloxegol in Treating Patients With Stage IIIB-IV Non-small Cell Lung Cancer

This randomized pilot clinical trial studies the side effects and best dose of naloxegol and to see how well it works in treating patients with stage IIIB-IV non-small cell lung cancer. Naloxegol may relieve some of the side effects of opioid pain medication and fight off future growth in the cancer.


Laboratory Biomarker Analysis, Naloxegol, Placebo, Quality-of-Life Assessment


Stage IIIB Non-Small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer


Pankaj Gupta, MD

See list of participating sites